Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? the REACT study protocol

Eitemau Tebyg

• Reduction of exacerbations by the PDE4 inhibitor roflumilast - the importance of defining different subsets of patients with COPD
  gan: Goehring Udo M, et al.
  Cyhoeddwyd: (2011-01-01)
• Reduction of exacerbations by the PDE4 inhibitor roflumilast - the importance of defining different subsets of patients with COPD
  gan: Rennard, Stephen I, et al.
  Cyhoeddwyd: (2011)
• Roflumilast: a review of its use in the treatment of COPD
  gan: Wedzicha, Jadwiga A, et al.
  Cyhoeddwyd: (2016)
• To Compare Reduction in Exacerbation of Severe COPD with Double Inhaled Therapy Plus Roflumilast Vs Double Inhaled Therapy Alone
  gan: Jahangir Ali , Rubina Aman ,Attiya Hameed , Hamza Masood
  Cyhoeddwyd: (2024-12-01)
• Use of a 4-week up-titration regimen of roflumilast in patients with severe COPD
  gan: Watz, Henrik, et al.
  Cyhoeddwyd: (2018)